Sit Acquires Sulmetin Fom Sanofi

SIT Group is pleased to announce the acquisition of established product SULMETIN from Sanofi, as a result of the agreement signed on November 8, 2022.

Now Online Centellase Website

The entire line of Centellase is illustrated on the new website, including the new product Centellase Cell Filler contorno occhi.